Trial Outcomes & Findings for Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) (NCT NCT02741193)
NCT ID: NCT02741193
Last Updated: 2023-11-14
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
2 participants
Primary outcome timeframe
30 minutes
Results posted on
2023-11-14
Participant Flow
Participant milestones
| Measure |
nTMS
Patients will receive a single-pulse TMS mapping of the motor area for the following reasons to determine the motor threshold, measure concurrent EMG, and mapping of the upper extremity.
The Magstim Rapid2,: Transcranial Magnetic Stimulation, which is a microprocessor-controlled machine which delivers both single and repetitive transcranial magnetic stimulation (TMS).
single and repetitive transcranial magnetic stimulation (TMS). TMS will be applied as single pulses to determine motor evoked potentials (MEPs), there will be no modulation of cortical excitability.
|
|---|---|
|
Overall Study
STARTED
|
2
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
nTMS
Patients will receive a single-pulse TMS mapping of the motor area for the following reasons to determine the motor threshold, measure concurrent EMG, and mapping of the upper extremity.
The Magstim Rapid2,: Transcranial Magnetic Stimulation, which is a microprocessor-controlled machine which delivers both single and repetitive transcranial magnetic stimulation (TMS).
single and repetitive transcranial magnetic stimulation (TMS). TMS will be applied as single pulses to determine motor evoked potentials (MEPs), there will be no modulation of cortical excitability.
|
|---|---|
|
Overall Study
Participant deemed not to be a surgical resection candidate
|
1
|
|
Overall Study
Participant found to be seizure-free due to new epilepsy medication, did not participate
|
1
|
Baseline Characteristics
Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 30 minutesPopulation: No participants had data collected for this outcome measure.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 30 minutesPopulation: No participants had data collected for this outcome measure.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 30 minutesPopulation: No participants had data collected for this outcome measure.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 30 minutesPopulation: No participants had data collected for this outcome measure.
Outcome measures
Outcome data not reported
Adverse Events
nTMS
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place